Marshall Wace North America’s Zai Lab ZLAB Stock Holding History

Marshall Wace North America’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.13M	Buy	+10,720	New	+$1.54M	﹤0.01%	880
2018 Q4	–	Sell	-168,626	Closed	-$3.29M	–	1663
2018 Q3	$3.29M	Buy	168,626 +5,234	+3%	+$114K	0.02%	396
2018 Q2	$3.8M	Sell	163,392 -44,877	-22%	-$968K	0.02%	586
2018 Q1	$4.45M	Sell	208,269 -53,206	-20%	-$1.21M	0.02%	595
2017 Q4	$5.55M	Buy	261,475 +170,387	+187%	+$4.53M	0.03%	553
2017 Q3	$2.46M	Buy	+91,088	New	+$2.54M	0.02%	747

Other funds holding ZLAB

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BAM

Brilliance Asset Management Admiralty, Hong Kong, Hong Kong $339M AUM 8.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Marshall Wace North America's ZLAB Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Zai Lab (ZLAB) in Q3 2021: 10,720 shares worth $1.13M. The stake represents ﹤0.01% of the portfolio and ranks #880 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in ZLAB as recently as Q3 2018.

Marshall Wace North America first reported a position in ZLAB in Q3 2017 and has held it in 6 quarters since. The position peaked at $5.55M in Q4 2017. 228 funds tracked by Wall St. Rank hold ZLAB as of Q3 2021.

Marshall Wace North America held 10,720 shares of Zai Lab worth $1.13M as of Q3 2021.
Zai Lab was a new Marshall Wace North America position in Q3 2021.
Zai Lab made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #880 holding.
Marshall Wace North America first reported a position in Zai Lab in Q3 2017 and has held it in 6 quarters since.
Marshall Wace North America's Zai Lab position peaked at $5.55M in Q4 2017.
228 funds tracked by Wall St. Rank held Zai Lab as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.